Spyre Therapeutics SYRE
NASDAQ SYRE
$90.33 -2.00 (-2.17%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Net Preferred Shares Issued and Repurchased (2015 - 2024)

Updated

Analysis

Spyre Therapeutics (SYRE) Net Preferred Shares Issued and Repurchased (2015 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Spyre Therapeutics 7.95 Bn 4.83 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -220,000.00
Jun 30, 2024 -135,000.00
Mar 31, 2024 169.21 Mn
Sep 30, 2023 -12.64 Mn
Jun 30, 2023 210.00 Mn
Sep 30, 2015 -5,000.00
Jun 30, 2015 6,000.00
Mar 31, 2015 43.68 Mn
API Access

Spyre Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=SYRE&period=max&api_key=YOUR_API_KEY